Company Data

Fusion Pharmaceuticals Inc.

Ticker
FUSN
Current Price
$21.55
Market Cap
$1.8B
Price Target
Refer to Report
Volume
593
52wk Range
$2.31 - $21.6
Advanced Market Data

Overview

Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm’s lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy